Literature DB >> 1555165

Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1555165      PMCID： PMC1488536     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

Authors:  J Eskola; H Käyhty; A K Takala; H Peltola; P R Rönnberg; E Kela; E Pekkanen; P H McVerry; P H Mäkelä
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

2.  Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.

Authors:  J Ward; G Brenneman; G W Letson; W L Heyward
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

3.  The 1990s: a decade of new vaccines.

Authors:  T V Murphy
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

Review 4.  Epidemiology of Haemophilus influenzae type b infections in the United States.

Authors:  C V Broome
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

5.  Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Authors:  S B Black; H R Shinefield; D Lampert; B Fireman; R A Hiatt; M Polen; E Vittinghoff
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

6.  Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Authors:  S B Black; H R Shinefield; B Fireman; R Hiatt; M Polen; E Vittinghoff
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

7.  Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.

Authors:  H Käyhty; H Peltola; J Eskola; P R Rönnberg; E Kela; V Karanko; P H Mäkelä
Journal:  Pediatrics       Date:  1989-12       Impact factor: 7.124

8.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.